GenAI has emerged as a beacon of innovation, offering businesses the promise of transformative capabilities. Yet, as organizations hasten to harness its potential, a glaring problem becomes evident: the journey from pilot to full-scale production is riddled with unexpected pitfalls, particularly in crafting a robust business case. This article delves into some of the reasons why GenAI initiatives fail to scale from promising pilots to production systems.
In 2023, many senior executives across various sectors were excited by the potential of GenAI to revolutionize business operations. With substantial investments and numerous pilots underway, the anticipation was palpable. However, the reality that unfolded was starkly different—most GenAI pilots struggled to progress beyond the experi
Council Post: The Case Of The Faulty Business Case
- By Raj Bhatt
- Published on
The journey from GenAI pilot to production is fraught with challenges that extend beyond technical implementation to encompass strategic planning and financial foresight.
